AXA/2025/FY/Earnings presentation

Document info
Organization	AXA
Year	2025
Period	FY
Period label	FY25
Document type	Analyst presentation
Publication date	2026-02-26
Language	English
Pages	49
Source	Original URL
Archive file	.md file

This article summarizes AXA's full-year 2025 earnings presentation, published on 26 February 2026.

Front matter

Full Year 2025 earnings presentation

• Full Year 2025 Earnings Presentation ^{p. 1}
• February 26, 2026 ^{p. 1}

Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures

• Certain statements are forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target' or conditional verbs such as 'would' and 'could' ^{p. 2}.
• Statements regarding expected underlying earnings per share ('UEPS') growth for 2026 are forward-looking statements providing one-off guidance for the last year of the Group's current strategic plan ^{p. 2}.
• These statements are based on Management's current views and intentions and are subject to change ^{p. 2}.
• Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties, many outside AXA's control, which could cause actual results to differ materially ^{p. 2}.
• Each forward-looking statement speaks only at the date of this presentation ^{p. 2}.
• Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of important factors, risks, and uncertainties ^{p. 2}.
• AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations ^{p. 2}.
• This presentation refers to certain non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management for analyzing operating trends, financial performance, and financial position ^{p. 2}.
• These non-GAAP financial measures generally have no standardized meaning and may not be comparable to similarly labeled measures used by other companies ^{p. 2}.
• None of these non-GAAP financial measures should be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS ^{p. 2}.
• Underlying earnings, UEPS ('underlying earnings per share'), underlying return on equity, combined ratio, and debt gearing are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015 ^{p. 2}.
• AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' ^{p. 2}.
• For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report ^{p. 2}.
• AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) ^{p. 2}.
• AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors ^{p. 2}.

Table of contents

• 1. FY25 Highlights: presented by Thomas Buberl, Group CEO, starting on page 04 ^{p. 3}.
• 2. FY25 Business Performance: presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on page 09 ^{p. 3}.
• 3. FY25 Financial Performance: presented by Alban de Mailly Nesle, Group CFO, starting on page 13 ^{p. 3}.

FY25 Highlights

1 FY25 Highlights

• FY25 Highlights ^{p. 4}
• Thomas Buberl, Group CEO ^{p. 4}

Full Year 2025 | Excellent performance

• Revenues +6% vs. FY24 ^{p. 5}
• Underlying EPS +8% vs. FY24 ^{p. 5}
• ROE FY25: 16% ^{p. 5}
• Solvency II ratio FY25: 224% ^{p. 5}
• Delivering value for shareholders with DPS +8% growth and EUR 1.25bn annual share buy back ^{p. 5}.
  • DPS growth is based on the dividend proposed by AXA's Board of Directors on February 25, 2026, and is subject to approval by the Shareholders' Annual General Meeting on April 30, 2026 ^{p. 5}.
  • The annual share buy back follows AXA's Board of Directors' approval on February 25, 2026, and is expected to commence as soon as reasonably practicable, subject to market conditions ^{p. 5}.
• Confident to deliver underlying EPS growth at the upper end of 6%-8% target range for 2026 ^{p. 5}.

Executing the plan on growth, margin and efficiency

Underlying earnings and top line growth ^{p. 6}

EUR billion	FY24	FY25	Change
Underlying earnings	8.1	8.4	+6% overall, +9% excluding AXA IM
P&C top line growth	—	—	+5%
Life top line growth	—	—	+9%
Health top line growth	—	—	+5%

• Record profitability: Further margin expansion in P&C and L&H; improvement in efficiency ^{p. 6}
• Scaling the business: Continued investments in growth and technology ^{p. 6}
• Consistent earnings growth while enhancing reserve prudence ^{p. 6}
• Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX ^{p. 6}.

Diversified franchise, well positioned in an attractive industry

FY25 gross written premium split (excluding AXA IM and holdings) ^{p. 7}

Segment	Share
Life	33%
Health	17%
Large & Specialty	17%
SME & Mid-market	16%
Retail	17%

• Secular trends fueling demand across businesses: ^{p. 7}
  • Protection gaps and emerging corporate risks (relevant for SME & Mid-market and Large & Specialty segments) ^{p. 7}
    • Demographics driving demand for private retirement and healthcare (relevant for Life and Health segments) ^{p. 7}
• Our right to win: ^{p. 7}
  • Leading brand & high customer NPS ^{p. 7}
  • Strong and diversified distribution ^{p. 7}
  • Technical expertise to price & underwrite risks ^{p. 7}
  • Scale offering cost advantage ^{p. 7}
• Pie chart represents FY25 gross written premium split excluding AXA IM and holdings ^{p. 7}.

Laying the foundation for the next plan

• (icon) Clear tech and AI roadmap ^{p. 8}
• (icon) Driving efficiency ^{p. 8}
• (icon) Enhancing capital allocation discipline ^{p. 8}
• (icon) Building resilience ^{p. 8}
• Confidence in sustaining earnings growth ^{p. 8}

• Guillaume Borie ^{p. 9}
• Global Head of Finance, Strategy, Underwriting, Risk, and Technology ^{p. 9}
• FY25 Business Performance ^{p. 9}

Strong delivery across our businesses

Strong delivery across our businesses

Performance by geography, FY25 ^{p. 10}

Region	% of total GWP	Gross written premiums (EUR billion)	Underlying earnings (EUR billion)
France	27%	31 (+6%)	2.2 (+7%)
Europe	38%	43 (+6%)	3.5 (+9%)
AXA XL	17%	19 (+4%)	1.9 (+9%)
Asia, Africa & EME-LATAM	18%	20 (+13%)	1.5 (+6%)

• Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX ^{p. 10}.
• ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers ^{p. 10}.

P&C | Strong margins, confidence in sustaining growth

• Underlying earnings +9% to EUR 5.9bn (change FY25 vs. FY24 at constant FX) ^{p. 11}
• (donut) GWP EUR 58bn ^{p. 11}
  • Retail: 34% ^{p. 11}
  • SME & Mid-market: 33% ^{p. 11}
  • AXA XL (Large & Specialty): 33% (includes AXA XL Re premiums of EUR 2.6bn) ^{p. 11}
• (diagram) 2025 Strategic Focus ^{p. 11}
  • Retail and SME & Mid-market: Growing volumes while expanding margins ^{p. 11}
  • AXA XL (Large & Specialty): Profitable growth with stable margins ^{p. 11}
• (diagram) Beyond 2025 Strategic Focus ^{p. 11}
  • Retail and SME & Mid-market: Investing to improve customer retention & expanding distribution footprint ^{p. 11}
  • AXA XL (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management ^{p. 11}
• (diagram) Additional Strategic Initiatives ^{p. 11}
  • Continued progress on efficiency ^{p. 11}
  • Higher investment income ^{p. 11}
  • Data & AI to further enhance customer experience & technical excellence ^{p. 11}

L&H | Good momentum, well positioned to capture growth opportunities

GWP breakdown by term ^{p. 12}

GWP EUR 57bn	—
Short-term	28%
Long-term	72%

• Underlying earnings +7% to EUR 3.5bn (change FY25 vs. FY24 at constant FX) ^{p. 12}
• (diagram) 2025 Strategic Focus ^{p. 12}
  • Long-term business: Accelerating net flows in Savings at attractive margins ^{p. 12}
  • Short-term business: Growing technical results while absorbing Mexico VAT impact ^{p. 12}
• (diagram) Beyond 2025 Strategic Focus ^{p. 12}
  • Long-term business: Capturing savings & retirement opportunity, sourcing best asset management products for our customers ^{p. 12}
  • Short-term business: Capitalizing on demand for health & protection while further improving our margins ^{p. 12}
• (diagram) Additional Strategic Initiatives ^{p. 12}
  • Focus on cost reduction ^{p. 12}
  • Increasing penetration of Protection riders in Savings offerings ^{p. 12}
  • Leveraging AI to reduce claims leakage & improve customer outcomes in Health ^{p. 12}
• FY25 Financial Performance ^{p. 13}
• Alban de Mailly Nesle ^{p. 13}
• Group CFO ^{p. 13}

P&C | Continued disciplined growth

• (stacked bar) GWP & Other Revenues ^{p. 14}
  • FY24 Total: EUR 56.5bn ^{p. 14}
    • Commercial lines: EUR 35.8bn ^{p. 14}
    • AXA XL Reinsurance: EUR 2.6bn ^{p. 14}
    • Retail lines: EUR 18.1bn ^{p. 14}
  • FY25 Total: EUR 58.0bn ^{p. 14}
    • Commercial lines: EUR 35.8bn ^{p. 14}
    • AXA XL Reinsurance: EUR 2.6bn ^{p. 14}
    • Retail lines: EUR 19.7bn ^{p. 14}
• Commercial lines: +4% change (o/w pricing +2%, o/w volume +2%) ^{p. 14}
  • Continued pricing momentum and volume growth in Mid-market and SME ^{p. 14}
• AXA XL Reinsurance: +8% change (o/w pricing +0.3%, o/w volume +7%) ^{p. 14}
  • Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance ^{p. 14}
  • Growth supported by alternative capital ^{p. 14}
• Retail lines: +7% change (o/w pricing +5%, o/w volume +2%) ^{p. 14}
  • Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) ^{p. 14}
• Change at constant scope and FX ^{p. 14}

P&C | Delivering further margin expansion while enhancing reserve prudence

• (stacked bar) Combined ratio ^{p. 15}
  • FY24 Total Combined Ratio: 91.0% ^{p. 15}
    • Undiscounted CY loss ratio (ex Nat Cat): 67.4% ^{p. 15}
    • Expense ratio: 25.0% ^{p. 15}
    • Nat Cat: 3.8% ^{p. 15}
    • Prior year reserve development: -1.6% ^{p. 15}
    • Discount: -3.6% ^{p. 15}
  • FY25 Total Combined Ratio: 90.6% ^{p. 15}
    • Undiscounted CY loss ratio (ex Nat Cat): 67.0% ^{p. 15}
    • Expense ratio: 24.8% ^{p. 15}
    • Nat Cat: 3.4% ^{p. 15}
    • Prior year reserve development: -1.1% ^{p. 15}
    • Discount: -3.5% ^{p. 15}
• Better undiscounted current year loss ratio excluding Nat Cat from: ^{p. 15}
  • Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment ^{p. 15}
  • Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management ^{p. 15}
• Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology ^{p. 15}
• Nat Cat charges below normalized load ^{p. 15}
• Lower reliance on prior year reserve development ^{p. 15}
• Taking advantage of a good year to enhance reserve prudence ^{p. 15}

P&C | Earnings growth from higher underwriting and financial result

Underlying Earnings waterfall ^{p. 16}

EUR million	FY24	Change	FY25
FY24	5,510	—	—
Volume growth	—	+292	—
Margin improvement	—	+189	—
Investment income	—	+435	—
Insurance finance expenses	—	-235	—
Tax	—	-169	—
Affiliates, FX & other	—	-150	—
FY25	—	—	5,872

• Underlying Earnings +9% (change at constant FX) ^{p. 16}
• Better underwriting result from strong volume growth and improved all-year combined ratio while enhancing reserve prudence ^{p. 16}
• Increase in investment income reflecting higher volumes and better reinvestment yields on fixed income assets ^{p. 16}
• Higher unwind of discount of claims reserves, in line with guidance ^{p. 16}
• Unfavorable forex impact notably due to USD depreciation vs. EUR ^{p. 16}

Life & Health | Strong growth in premiums, positive net flows

• (bar) Life GWP & Other Revenues +9% (change at constant scope and FX) ^{p. 17}
  • FY24 Total: EUR 34.5bn ^{p. 17}
    • Protection: EUR 17.3bn ^{p. 17}
    • Unit-linked: EUR 9.3bn ^{p. 17}
    • Capital light G/A: EUR 6.0bn ^{p. 17}
    • Traditional G/A: EUR 1.9bn ^{p. 17}
  • FY25 Total: EUR 37.5bn ^{p. 17}
    • Protection: EUR 19.0bn (+11%) ^{p. 17}
    • Unit-linked: EUR 10.5bn (+13%) ^{p. 17}
    • Capital light G/A: EUR 6.1bn (+7%) ^{p. 17}
    • Traditional G/A: EUR 1.9bn (-7%) ^{p. 17}
• (bar) Health GWP & Other Revenues +5% (change at constant scope and FX) ^{p. 17}
  • FY24 Total: EUR 17.5bn ^{p. 17}
    • Individual: EUR 10.5bn ^{p. 17}
    • Group: EUR 7.0bn ^{p. 17}
  • FY25 Total: EUR 19.0bn ^{p. 17}
    • Individual: EUR 11.1bn (+6%) ^{p. 17}
    • Group: EUR 7.9bn (+4%) ^{p. 17}
• (bar) Net flows: EUR +5.4bn vs. EUR +1.5bn in FY24 ^{p. 17}
  • Protection: +EUR 4.9bn ^{p. 17}
  • Health: +EUR 2.7bn ^{p. 17}
  • Unit-Linked: +EUR 1.5bn ^{p. 17}
  • Capital light G/A: +EUR 1.2bn ^{p. 17}
  • Traditional G/A: -EUR 5.0bn ^{p. 17}
• Employee Benefits (including both short-term and long-term Employee Benefits GWP and other revenues) FY25: EUR 12.9bn (+4% vs. FY24) ^{p. 17}

Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting

• PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes (change at constant scope and FX) ^{p. 18}
• (bar) PVEP -2% ^{p. 18}
  • FY24 Total: EUR 50.9bn ^{p. 18}
    • Protection & Health: EUR 39.4bn ^{p. 18}
    • Unit-Linked: EUR 8.5bn ^{p. 18}
    • Capital-light G/A: EUR 2.0bn ^{p. 18}
    • Traditional G/A: EUR 1.0bn ^{p. 18}
  • FY25 Total: EUR 49.4bn ^{p. 18}
    • Protection & Health: EUR 31.4bn (-4%) ^{p. 18}
    • Unit-Linked: EUR 8.5bn (+18%) ^{p. 18}
    • Capital-light G/A: EUR 7.8bn (-10%) ^{p. 18}
    • Traditional G/A: EUR 1.7bn (-10%) ^{p. 18}
• NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits ^{p. 18}
• (bar) NB CSM (pre-tax) +3% ^{p. 18}
  • FY24: EUR 2.2bn ^{p. 18}
  • FY25: EUR 2.2bn ^{p. 18}
• NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France ^{p. 18}
• (bar) NBV (post-tax) stable ^{p. 18}
  • FY24: EUR 2.3bn ^{p. 18}
  • FY25: EUR 2.2bn ^{p. 18}
  • NBV margin: FY24 4.4%, FY25 4.5% ^{p. 18}

Life & Health | Growth in new business driving Normalized CSM growth

• Normalized CSM up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates (change at constant scope and FX) ^{p. 19}
• (waterfall) Contractual Service Margin rollforward:
  • FY24: EUR 33.6bn ^{p. 19}
  • New business CSM: +EUR 2.2bn ^{p. 19}
  • Underlying return on in-force: +EUR 1.3bn ^{p. 19}
  • CSM release: -EUR 3.0bn ^{p. 19}
  • Economic variance: +EUR 0.6bn ^{p. 19}
  • Operating variance: -EUR 0.3bn ^{p. 19}
  • Affiliates, FX & other: -EUR 1.4bn ^{p. 19}
  • FY25: EUR 33.0bn ^{p. 19}
• Economic variance reflecting government spreads tightening and positive equity market returns ^{p. 19}
• Operating variance driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland ^{p. 19}
• FX impact mainly from JPY and HKD depreciation ^{p. 19}
• CSM o/w Life: FY24 EUR 25.8bn, FY25 EUR 25.4bn ^{p. 19}
• CSM o/w Health: FY24 EUR 7.7bn, FY25 EUR 7.6bn ^{p. 19}

Life & Health | Strong momentum in both short-term and long-term business

Underlying Earnings waterfall ^{p. 20}

EUR million	FY24	Change	FY25
FY24	3,323	—	—
Short-term technical margin	—	+60	479
Long-term result incl. CSM release	—	+156	2,804
Financial result	—	-11	946
Tax, FX and others	—	-27	-728
FY25	—	—	3,501

• Underlying Earnings +7% (change at constant FX) ^{p. 20}
• Strong short-term technical margin reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) ^{p. 20}
• Higher long-term results from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins ^{p. 20}
• Underlying Earnings o/w Life: FY24 EUR 2.6bn, FY25 EUR 2.7bn (+4% vs. FY24) ^{p. 20}
• Underlying Earnings o/w Health: FY24 EUR 0.7bn, FY25 EUR 0.8bn (+17% vs. FY24) ^{p. 20}

Growth in net income reflecting higher earnings & the gain from the sale of AXA IM

Growth in net income reflecting higher earnings & the gain from the sale of AXA IM

Underlying earnings and net income by segment ^{p. 21}

EUR billion	FY24	FY25	Change
Underlying earnings (constant FX)	8.1	8.4	+6%
Property & Casualty	—	5.9	+9%
Life & Health	—	3.5	+7%
Asset Management	—	0.2	-57%
Holdings & other	—	-1.2	stable
Net income (reported)	7.9	9.8	+26%
Non-financial flows	-0.5	+2.1	—
Capital gains from AXA IM disposal	—	+2.2	—
Financial flows (incl. RCG)	+0.3	-0.7	—

• (bar) Underlying earnings per share: EUR 3.86 (FY25) vs EUR 3.59 (FY24), +8% ^{p. 21}
  • +6% from earnings growth ^{p. 21}
  • +3% from capital management ^{p. 21}
  • -2% from forex ^{p. 21}
    • Including -1% from temporary earnings dilution from AXA IM sale due to timing of anti-dilutive share buyback ^{p. 21}
• Underlying earnings driven by strong performance from insurance businesses ^{p. 21}
• Holding cost stable, expected to remain at current level in 2026 ^{p. 21}
• Net income mainly reflecting higher underlying earnings and the gain from the sale of AXA IM ^{p. 21}
• Financial flows lower, reflecting unfavorable forex impact ^{p. 21}

Shareholders' equity and related metrics ^{p. 22}

EUR billion	FY24	HY25	FY25
Shareholders' equity (Group share)	—	—	—
SHE (excl. OCI)	58.0	52.7	54.0
Net OCI	-8.1	-7.2	-6.8
SHE (excl. OCI & undated subordinated debt)	53.2	47.0	49.4
Debt gearing	20.6%	23.4%	22.3%
Underlying ROE	15.2%	17.5%	16.0%

Reconciliation of Shareholders' Equity ^{p. 22}

EUR billion	FY24 to FY25	HY25 to FY25
Opening Shareholders' equity	49.9	45.5
Change in Net OCI	1.3	0.4
Net income for the period	9.8	5.9
Dividend	-4.6	—
Annual share buyback	-1.2	—
Anti-dilutive share buyback following the sale of AXA IM	-3.5	-3.5
Undated subordinated debt (including interest charges)	-0.3	-1.2
Forex	-3.5	-0.1
Other	-0.6	0.3
Closing Shareholders' equity	47.2	47.2

Higher organic cash remittance and robust cash position at Holding

Higher organic cash remittance and robust cash position at Holding

Cash Remittance and Cash Position ^{p. 23}

EUR billion	FY24	FY25
Net Cash Remittance	7.7	7.5
Remittance ratio	82%	82%

• FY24 breakdown: EUR 7.1bn (ordinary cash remittance) + EUR 0.6bn (proceeds related to in-force treaties²) ^{p. 23}
• FY24 Cash position: EUR 4.0bn ^{p. 23}
• Net cash remittance from subsidiaries: +EUR 7.5bn ^{p. 23}
• Dividend: -EUR 4.6bn ^{p. 23}
• Annual share buyback: -EUR 1.2bn ^{p. 23}
• Anti-dilutive share buyback following the sale of AXA IM: -EUR 3.5bn ^{p. 23}
• Holding costs and interest expenses: -EUR 1.3bn ^{p. 23}
• Change in net debt: +EUR 1.6bn ^{p. 23}
• M&A and other: +EUR 3.1bn ^{p. 23}
• FY25 Cash position: EUR 5.6bn ^{p. 23}
• ¹Based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 ^{p. 23}.
• ²EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe ^{p. 23}.

Solvency II at 224%

Solvency II at 224%

Solvency II metrics and sensitivities ^{p. 24}

EUR billion	FY24	FY25
Eligible Own Funds (EOF)	55.9	56.4
Solvency Capital Requirement (SCR)	25.9	25.2
Solvency II ratio	216%	224%

• Changes: +EUR 0.2bn, +EUR 8.8bn, -EUR 0.4bn, -EUR 2.1bn, -EUR 6.0bn (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn), -EUR 0.1bn ^{p. 24}
• Changes: EUR 0.0bn, +EUR 0.6bn, EUR 0.0bn, -EUR 1.2bn, EUR 0.0bn, -EUR 0.2bn ^{p. 24}
• Solvency II ratio: 224% (FY25) vs 216% (FY24) ^{p. 24}
  • Regulatory & model changes: +0pts ^{p. 24}
  • Normalized capital generation: +28pts ^{p. 24}
  • Operating variance: -1pt ^{p. 24}
  • Economic & FX: +4pts ^{p. 24}
  • Dividend & annual share buyback: -24pts ^{p. 24}
  • Management actions, debt & other: +2pts ^{p. 24}

Key sensitivities on Solvency II Ratio as of December 31, 2025 (224%) ^{p. 24}

Sensitivity	Impact (pts)
Interest rate +50bps	+2
Interest rate -50bps	-1
Corporate spreads +50bps	-1
Euro Sovereign spreads +50bps	-7
Credit migration	-4
Listed Equity (excl. PE & Infra) +25%	-1
Listed Equity (excl. PE & Infra) -25%	+2
PE & Infra +25%	+14
PE & Infra -25%	-19
Inflation swap curve +50bps	-5

• ¹Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures) ^{p. 24}.
• ²Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches) ^{p. 24}.

Solvency II -impact of the end of grandfathering period and Solvency II revision

Solvency II Ratio adjustments ^{p. 25}

Item	Impact
Ratio as of 31/12/2025	224%
Impact of the end of grandfathering period on January 1, 2026	-10pts to 215%
Impact of Solvency II revision to come into effect in 1Q27	+17pts

• EUR 2.4bn grandfathered debt no longer eligible as capital from January 1, 2026 ^{p. 25}
• No change expected in organic capital generation ^{p. 25}
• Additional capital flexibility ^{p. 25}
• ¹Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date ^{p. 25}.

Thomas Buberl, Group CEO conclusion

Thomas Buberl, Group CEO conclusion

• Conclusion by Thomas Buberl, Group CEO ^{p. 26}

Conclusion

Conclusion

• Record results, at the top end of the target range while enhancing reserve prudence ^{p. 27}
• All businesses in excellent shape, delivering strong growth and profitability ^{p. 27}
• Diversified franchise, well-positioned to capture future growth opportunities ^{p. 27}
• Laying foundations for the next plan and confident in delivering sustainable earnings growth ^{p. 27}

Q&A Full Year 2025 earnings

February 26, 2026 Q&A Full Year 2025 earnings

• Q&A for Full Year 2025 Earnings ^{p. 28}
• Date: February 26, 2026 ^{p. 28}

AXA Investor Relations | Keep in touch

• Meet our management ^{p. 29}
  • March: Roadshows in Europe and US ^{p. 29}
  • May 5: 1Q25 Activity Indicators in Paris ^{p. 29}
  • June 2: BNP Paribas Exane CEO Conference in Paris ^{p. 29}
  • June 2-4: Goldman Sachs European Financials Conference in Zurich ^{p. 29}
  • July 31: HY26 Earnings Release in Paris ^{p. 29}
  • September 21: AXA Investor Day in London ^{p. 29}
• Contact us ^{p. 29}
  • Investor Relations: +33 1 40 75 48 42 ^{p. 29}
  • Email: investor.relations@axa.com ^{p. 29}
• Follow us ^{p. 29}
  • Website: www.axa.com ^{p. 29}
  • Social media icons for YouTube, Facebook, Instagram, Twitter, LinkedIn, and a leaf icon ^{p. 29}

Appendices

Appendices

• Appendices ^{p. 30}

• Debt and Invested Assets p.31
• Additional P&C disclosures p.36
• Additional IFRS17 disclosures p.41
• Sustainability p.44

Gross financial debt and maturity breakdown as of December 31st, 2025

• (stacked bar) Gross financial debt (EUR bn):
  • FY24: Total EUR 19.2bn; Tier 1 EUR 3.5bn, Tier 2 EUR 10.8bn, Senior debt EUR 4.8bn ^{p. 32}
  • FY25: Total EUR 22.3bn; Tier 1 EUR 3.5bn, Tier 2 EUR 12.2bn, Senior debt EUR 4.6bn ^{p. 32}
  • Jan 1st 2026 (End of the grandfathering period): Total EUR 20.3bn; Tier 1 EUR 5.8bn (o/w EUR 0.4bn redeemed in Jan 2026), Tier 2 EUR 11.3bn, Senior debt EUR 3.2bn ^{p. 32}
• Debt gearing: 20.6% for FY24; 22.3% for FY25 ^{p. 32}
• (stacked bar) Contractual maturity breakdown (EUR bn):
  • 2025: Senior debt 0.5, Tier 2 0.5, Tier 1 0.5 ^{p. 32}
  • 2026: Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 ^{p. 32}
  • 2027: Senior debt 0.5, Tier 2 0.5, Tier 1 0.5 ^{p. 32}
  • 2028: Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 ^{p. 32}
  • 2029: Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 ^{p. 32}
  • 2030: Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 ^{p. 32}
  • 2031-2039: Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 ^{p. 32}
  • ≥2040: Senior debt 10.8, Tier 2 0.2, Tier 1 1.4 ^{p. 32}
  • Undated: Senior debt 4.6, Tier 2 0.7, Tier 1 0.5 ^{p. 32}
• o/w Grandfathered debt (Contractual maturity, EUR bn):
  • 2031-2039: Tier 1 0.7, Tier 2 0.2 ^{p. 32}
  • ≥2040: Tier 1 0.2 ^{p. 32}
  • Undated: Tier 1 0.5 ^{p. 32}
• (stacked bar) Economic maturity breakdown (EUR bn):
  • 2025: Senior debt 0.1, Tier 2 0.1, Tier 1 0.1 ^{p. 32}
  • 2026: Senior debt 0.1, Tier 2 0.1, Tier 1 0.1 ^{p. 32}
  • 2027: Senior debt 2.4, Tier 2 0.1, Tier 1 0.1 ^{p. 32}
  • 2028: Senior debt 2.0, Tier 2 0.1, Tier 1 0.1 ^{p. 32}
  • 2029: Senior debt 0.9, Tier 2 0.1, Tier 1 0.1 ^{p. 32}
  • 2030: Senior debt 0.7, Tier 2 0.1, Tier 1 0.1 ^{p. 32}
  • 2031-2039: Senior debt 6.4, Tier 2 0.2, Tier 1 1.5 ^{p. 32}
  • ≥2040: Senior debt 0.5, Tier 2 0.1, Tier 1 0.7 ^{p. 32}
  • Undated: Senior debt 4.0, Tier 2 0.1, Tier 1 0.7 ^{p. 32}
• o/w Grandfathered debt (Economic maturity, EUR bn):
  • 2031-2039: Tier 1 0.7, Tier 2 0.2 ^{p. 32}
  • ≥2040: Tier 1 0.2 ^{p. 32}
  • Undated: Tier 1 0.8 ^{p. 32}
• Nominal debt ^{p. 32}
• In January 2026, AXA has called (i) the remaining T2 GF GBP 139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF EUR 250m perpetual callable 2010 floating issued January 2005 ^{p. 32}
• Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt ^{p. 32}
• For Solvency 2 RT1 debt, which has no step-up, the undated nature of the instrument is retained for the purpose of this diagram ^{p. 32}
• This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable ^{p. 32}
• Such decision will depend on several factors, including capital and liquidity position and refinancing economics at the prevailing time ^{p. 32}

General Account invested assets

FY25 Total General Account invested assets ^{p. 33}

EUR billion	%
Fixed income	345	77
o/w Government bonds	167	37
o/w Corporate bonds and loans	121	27
o/w Other fixed income	56	13
Real estate	41	9
Infrastructure equity	10	2
Listed equities	10	2
Private equity and hedge funds	23	5
Cash	19	4
Policy loans	2	0
Total Insurance Invested Assets	450	100

• Duration gap: -0.4 year ^{p. 33}
• ¹ Other fixed income includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) ^{p. 33}
• ² Listed equities includes hedges; Listed equities excluding hedges at EUR 14bn ^{p. 33}
• ³ Private equity and hedge funds includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) ^{p. 33}
• ⁴ Please refer to the financial supplement for more details ^{p. 33}

Structured and Private Credit assets

FY25 Invested assets by type ^{p. 34}

EUR billion	% of G/A portfolio
Residential Mortgages	16	4
EUR 6bn Dutch mortgages, NHG guaranteed	—	—
EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)	—	—
CLO & ABS	25	6
91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)	—	—
Infrastructure debt	8	2
Skewed towards resilient industries (Telecom, Utilities, Transport)	—	—
CRE debt	8	2
Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV	—	—
Mid-Market lending	10	2
Strong diversification with EUR 8m average ticket	—	—
Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation	—	—
Other	2	0
Total Structured and Private Credit Assets	69	15
o/w 54% participating	—	—

• G/A: General Account ^{p. 34}

Investment portfolio | Fixed Income reinvestment

FY25 Fixed Income Reinvestment ^{p. 35}

Category	%	Average rating
Government bonds & related	32	AA
Investment grade credit	40	A
ABS/CLO/IG fund financing	21	—
Below investment grade credit	7	—

FY25 Fixed Income Reinvestment Yield ^{p. 35}

Category	Yield
Public fixed income	3.5%
Private & Structured fixed income	4.7%
Total fixed income	3.9%

• Euro 57 billion fixed income invested at 3.9% ^{p. 35}
  • Average duration of 9 years ^{p. 35}
  • Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) ^{p. 35}
  • Gradual shift from alternative total return assets to Private & Structured credit ^{p. 35}
• ¹ Government bonds & related refers to Government and Corporate bonds and related ^{p. 35}
• ² Private & Structured fixed income refers to Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) ^{p. 35}

Table of contents ^{p. 36}

Section	Page
1. Debt and Invested Assets	31
2. Additional P&C disclosures	36
3. Additional IFRS17 disclosures	41
4. Sustainability	44

AXA XL Insurance | Large Commercial & Specialty business

• Well diversified across lines of business and geographies ^{p. 37}
  • (pie) FY25 GWP by line of business: Total USD 19bn ^{p. 37}
    • Casualty: 35% ^{p. 37}
    • Property: 29% ^{p. 37}
    • Specialty: 19% ^{p. 37}
    • Professional lines: 17% ^{p. 37}
  • (pie) FY25 GWP by geography: Total USD 19bn ^{p. 37}
    • Americas: 46% ^{p. 37}
    • Europe & APAC: 35% ^{p. 37}
    • UK & Lloyds: 19% ^{p. 37}
• Leading market positions across lines ^{p. 37}
  • Top 3 globally ^{p. 37}
    • Multinational Programs (Source: McKinsey) ^{p. 37}
    • Marine (Source: Aon, Guy Carpenter, and Global Market Insights) ^{p. 37}
    • Fine Art & Specie (Source: Industry Research Biz (January 2026)) ^{p. 37}
• Managing the cycle to deliver consistent profitability ^{p. 37}
  • (scatter plot) Profitability vs. Ex-price growth:
    • Property (top right) ^{p. 37}
    • Specialty (middle right) ^{p. 37}
    • Casualty (middle left) ^{p. 37}
    • Professional lines (bottom left) ^{p. 37}

P&C | Focus on Reserves

Claims reserves ratio (Net undiscounted claims reserves/Net earned premiums) ^{p. 38}

Year	IFRS4	IFRS17
FY18	179%	—
FY19	185%	—
FY20	193%	—
FY21	188%	—
FY22	189%	198%
FY23	—	195%
FY24	—	180%
FY25	—	175%

Technical reserves ratio (Net undiscounted technical reserves /Net earned premiums) ^{p. 38}

Year	IFRS4	IFRS17
FY18	213%	—
FY19	227%	—
FY20	233%	—
FY21	226%	—
FY22	227%	234%
FY23	—	232%
FY24	—	216%
FY25	—	210%

• Technical reserves include net undiscounted claims reserves and unearned premium reserves ^{p. 38}

P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1

• Stable retention levels maintained in 2026 as in 2025 ^{p. 39}
• (bar) Insurance segment (occurrence protection) in Euro:
  • EU Windstorm: Capacity EUR 4.0bn, Retention EUR 600m ^{p. 39}
  • Europe Flood: Capacity EUR 2.1bn, Retention EUR 450m ^{p. 39}
  • Europe Earthquake: Capacity EUR 2.1bn, Retention EUR 400m ^{p. 39}
  • NA Hurricane: Capacity EUR 1.2bn, Retention EUR 600m ^{p. 39}
  • NA Earthquake: Capacity EUR 1.2bn, Retention EUR 600m ^{p. 39}
  • Per other perils: Capacity [unclear, visually around EUR 0.8bn], Retention EUR 400m ^{p. 39}
    • Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils ^{p. 39}
    • Capacity varies by peril type ^{p. 39}
• (diagram) Reinsurance segment (illustrative): Alternative Capital & Cat Bonds ^{p. 39}
• Excludes local reinsurance covers ^{p. 39}
• Varying retention between MX and NA (EUR 400m MX, EUR 600m NA) ^{p. 39}

P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026

• Group underlying earnings deviation to average Nat Cat charges in 2026 net of reinsurance, post-tax (in Euro billion) ^{p. 40}
  • (bar) More severe years - Negative deviation in ca. 40% of cases:
    • 1/20y (95th percentile): -EUR 1.2bn ^{p. 40}
    • 1/10y (90th percentile): -EUR 0.8bn ^{p. 40}
    • 1/5y (80th percentile): -EUR 0.4bn ^{p. 40}
  • (bar) Median (50th percentile): EUR 0.1bn ^{p. 40}
  • (bar) Less severe years - Positive deviation in ca. 60% of cases:
    • 1/5y (20th percentile): EUR 0.5bn ^{p. 40}
    • 1/10y (10th percentile): EUR 0.7bn ^{p. 40}
    • 1/20y (5th percentile): EUR 0.8bn ^{p. 40}
• Average Expected Nat Cat charges net of reinsurance, pre-tax (in Euro billion) ^{p. 40}
  • (bar) 2025: EUR 2.6bn; Estimated impact on GEP ca. 4.5% ^{p. 40}
  • (bar) 2026: EUR 2.7bn; Estimated impact on GEP ca. 4.5% ^{p. 40}
• Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance ^{p. 40}
• Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance) ^{p. 40}

• 1. Debt and Invested Assets ^{p. 31}
• 2. Additional P&C disclosures ^{p. 36}
• 3. Additional IFRS17 disclosures ^{p. 41}
• 4. Sustainability ^{p. 44}

P&C | Margin analysis

• (flow) Technical Result (in EUR million, pre-tax) ^{p. 42}
  • Current Accident Year Undiscounted Technical Margin: EUR 2,778 (change: +EUR 707) ^{p. 42}
    • Gross Earned Premiums: EUR 57,656 (+6%) ^{p. 42}
    • Current Accident Year Undiscounted Combined Ratio: 95.2% (-1.0pt) ^{p. 42}
    • o/w Nat Cats: 3.4% (-0.4pt) ^{p. 42}
  • Current Accident Year Discounting: EUR 2,009 (change: +EUR 115) ^{p. 42}
    • Discounting Ratio (in Combined Ratio points): -3.5% (+0.0pt) ^{p. 42}
    • Current Accident Year Net Claims reserves: EUR 19.0bn ^{p. 42}
    • Duration: 4.0 years ^{p. 42}
    • Current Accident Year Discount Rate: 2.8% ^{p. 42}
  • Prior Years' Reserve Development (PYD): EUR 622 (change: -EUR 341) ^{p. 42}
    • PYD ratio: -1.1% (+0.7pt) ^{p. 42}
  • Sensitivity to Current Accident Year discount rate changes ^{p. 42}
    • +25bps: +EUR 0.2bn ^{p. 42}
    • -25bps: -EUR 0.2bn ^{p. 42}
• (flow) Financial Result (in EUR million, pre-tax) ^{p. 42}
  • Investment Income: EUR 3,988 (change: +EUR 435) ^{p. 42}
    • FY25 Average Assets: EUR 115bn ^{p. 42}
    • Asset book yield: 3.5% ^{p. 42}
    • FY25 Reinvestment yield¹: 4.3% ^{p. 42}
  • Insurance Finance Expenses: -EUR 1,358 (change: -EUR 235) ^{p. 42}
    • FY24 Reserves at locked-in rate: EUR 71bn ^{p. 42}
    • Liability book yield: 1.9% ^{p. 42}
  • 2025 Insurance Finance Expenses (pre-tax): ~EUR -1.4bn ^{p. 42}
  • Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount ^{p. 42}
    • +25bps: ~EUR -50m ^{p. 42}
    • -25bps: ~EUR +50m ^{p. 42}
• (flow) Underlying Earnings before tax: EUR 8,040 (change: +EUR 681) ^{p. 42}
  • Tax: -EUR 2,060 (change: -EUR 169) ^{p. 42}
  • Affiliates, Minority interests & Other: -EUR 108 (change: -EUR 10) ^{p. 42}
  • Underlying Earnings: EUR 5,872 (change: +EUR 501) ^{p. 42}
    • Growth vs. FY24 (at constant FX): +9% ^{p. 42}

L&H | Margin analysis

• Includes scope impact ^{p. 43}
• (flow) Technical Result (in EUR million, pre-tax) ^{p. 43}
  • Short-term Technical Margin: EUR 479 (change: +EUR 60) ^{p. 43}
    • Includes recapture of Laya ^{p. 43}
    • Gross Earned Premiums: EUR 17,416 (+10%) ^{p. 43}
    • All Year Combined Ratio: 97.2% (-0.1pts) ^{p. 43}
  • Long-term Technical Margin: EUR 2,804 (change: +EUR 156) ^{p. 43}
    • CSM release: EUR 2,954 (+EUR 215) ^{p. 43}
    • Technical experience: -EUR 150 (-EUR 58) ^{p. 43}
  • Life & Health FY25 CSM Key Sensitivities (in EUR billion) ^{p. 43}
    • Baseline: 33.3 ^{p. 43}
    • Interest rates +50bps: -0.8 ^{p. 43}
    • Interest rates -50bps: 0.6 ^{p. 43}
    • Sovereign spreads +50bps: -1.9 ^{p. 43}
    • Sovereign spreads -50bps: 1.9 ^{p. 43}
    • Corporate spread +50bps: -0.8 ^{p. 43}
    • Corporate spread -50bps: 0.8 ^{p. 43}
    • Equities +25%: 1.8 ^{p. 43}
    • Equities -25%: -2.2 ^{p. 43}
• (flow) Financial Result (in EUR million, pre-tax) ^{p. 43}
  • Investment Income (non-VFA only): EUR 2,484 (change: -EUR 1) ^{p. 43}
    • FY25 Average Assets: EUR 98bn ^{p. 43}
    • Asset book yield: 2.5% ^{p. 43}
    • FY25 Reinvestment yield¹: 3.8% ^{p. 43}
  • Insurance Finance Expenses (non-VFA only): -EUR 1,538 (change: -EUR 9) ^{p. 43}
    • FY24 Reserves at locked-in rate: EUR 62bn ^{p. 43}
    • Liability book yield: 2.5% ^{p. 43}
• (flow) Underlying Earnings before tax: EUR 4,229 (change: +EUR 205) ^{p. 43}
  • Tax: -EUR 800 (change: +EUR 65) ^{p. 43}
  • Affiliates, Minority interests & Other: EUR 72 (change: -EUR 51) ^{p. 43}
  • Underlying Earnings: EUR 3,501 (change: +EUR 219) ^{p. 43}
    • Growth vs. FY24 (at constant FX): +7% ^{p. 43}
• Invested assets (100%) (in EUR billion) ^{p. 43}
  • Residential Mortgages: EUR 16 (4% of total G/A portfolio) ^{p. 43}
    • EUR 6bn Dutch mortgages, NHG guaranteed ^{p. 43}
    • EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) ^{p. 43}
  • CLO & ABS: EUR 25 (6% of total G/A portfolio) ^{p. 43}
    • 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) ^{p. 43}
  • Infrastructure debt: EUR 8 (2% of total G/A portfolio) ^{p. 43}
    • Skewed towards resilient industries (Telecom, Utilities, Transport) ^{p. 43}
  • CRE debt: EUR 8 (2% of total G/A portfolio) ^{p. 43}
    • Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV ^{p. 43}
  • Mid-Market lending: EUR 10 (2% of total G/A portfolio) ^{p. 43}
    • Strong diversification with EUR 8m average ticket ^{p. 43}
    • Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation ^{p. 43}
  • Other: EUR 2 (0% of total G/A portfolio) ^{p. 43}
  • Total Structured and Private Credit Assets: EUR 69 (15% of total G/A portfolio) ^{p. 43}
    • o/w 54% participating ^{p. 43}

Expanding AXA's role in society: AXA for Progress Index 1

• As a Global INVESTOR ^{p. 45}
  • Target: EUR 5bn² in climate transition financing per year ^{p. 45}
  • 2025 Result: EUR 6.4bn ^{p. 45}
  • Target: EUR 500m² in community resilience financing per year ^{p. 45}
  • 2025 Result: EUR 1.4bn ^{p. 45}
• As a Global INSURER ^{p. 45}
  • Target: EUR 6bn³ in P&C GWP to support transition underwriting (cumulative 2024-2026) ^{p. 45}
  • 2025 Result: EUR 4.6bn ^{p. 45}
  • Target: >20,000⁴ climate adaptation solutions & services (cumulative 2024-2026) ^{p. 45}
    • Target revised in 2025 ^{p. 45}
  • 2025 Result: 19,698 Cumulative 2024-2025 ^{p. 45}
  • Target: >20m⁵ inclusive insurance customers by 2026 ^{p. 45}
  • 2025 Result: 20.6m ^{p. 45}
• As a COMPANY ^{p. 45}
  • Target: >80,000⁶ AXA Group employees trained on climate adaptation by 2026 ^{p. 45}
  • 2025 Result: 46,420 ^{p. 45}
  • Target: Contribute to Net-Zero -50%⁷ by 2030 in absolute carbon emissions and offset of residual emissions⁸ ^{p. 45}
  • 2025 Result: -64% Reduction against 2019 ^{p. 45}
  • Target: 50% Percentage of AXA Group employees engaged in volunteering activities by 2026 ^{p. 45}
  • 2025 Result: 56% ^{p. 45}
• Footnote 7: Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030. ^{p. 45}
• Footnote 8: Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage). ^{p. 45}

Sustainability Performance & Ratings

• S&P Global
  • 2025 percentile: 97th in Dow Jones Best-in-Class Europe & World indices ^{p. 46}
  • 2025 score: AAA ^{p. 46}
• MSCI
  • 2025 score: AAA ^{p. 46}
• CDP
  • 2025 score: B ^{p. 46}
• Morningstar Sustainalytics
  • 2025 ESG Risk Rating: 17.0 - Low risk ^{p. 46}
• FTSE Russell
  • 2025 score: 4.3/5 in FTSE4Good Index Series ^{p. 46}
• The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares) ^{p. 46}.
• Results as of February 6th, 2026 ^{p. 46}.

Scope

• France: includes insurance activities, banking activities and holding ^{p. 47}.
• Europe: includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxemburg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities) and AXA Life Europe (insurance activities) ^{p. 47}.
• AXA XL: includes insurance and reinsurance activities and holding ^{p. 47}.
• Asia, Africa & EME-LATAM: ^{p. 47}
  • Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated ^{p. 47}.
  • China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income ^{p. 47}.
  • Africa: Morocco (insurance activities and holding) and Nigeria (insurance activities and holding), Egypt (insurance activities and holding) which are fully consolidated ^{p. 47}.
  • EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated ^{p. 47}.
  • Russia (Reso) (insurance activities) which consolidated under the equity method and contributes only to the net income ^{p. 47}.
  • AXA Mediterranean Holdings ^{p. 47}.
• Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings ^{p. 47}.
• AXA Investment Managers (until July 1, 2025): includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method ^{p. 47}.
• Unless otherwise specified, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards that became effective on January 1, 2023 ^{p. 47}.
• Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 ^{p. 47}.

Glossary

• Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only or with guarantees equal to or lower than 0% ^{p. 48}.
• Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders ^{p. 48}.
• CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period ^{p. 48}.
• Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force ^{p. 48}.
• Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow ^{p. 48}.
• Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) ^{p. 48}.
• Other Revenues: represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) ^{p. 48}.
• New Business Value (NBV): the value of newly issued contracts during the current year ^{p. 48}.
  • It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests ^{p. 48}.
• New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided ^{p. 48}.
• New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP ^{p. 48}.
• Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes ^{p. 48}.
  • Operating variance is net of reinsurance ^{p. 48}.
• Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term ^{p. 48}.
  • PVEP is discounted at the reference interest rate and PVEP is Group share ^{p. 48}.
• Technical experience: consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses ^{p. 48}.
• Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance ^{p. 48}.

February 26, 2026 Thank you Full Year 2025 earnings

• Thank you ^{p. 49}.
• Full Year 2025 Earnings ^{p. 49}.
• February 26, 2026 ^{p. 49}.

Abbreviations

• ABS: Asset-Backed Securities
• AEP: Aggregate Exceedance Probability
• AI: Artificial Intelligence
• AMF: Autorité des marchés financiers
• APAC: Asia-Pacific
• AY: Accident Year
• BBA: Bearer Bond
• CDP: Carbon Disclosure Project
• CLO: Collateralized Loan Obligation
• CRE: Commercial Real Estate
• CSA: Corporate Sustainability Assessment
• CSM: Contractual Service Margin
• CY: Calendar Year
• DPS: Dividend Per Share
• EME: Emerging Markets
• EOF: Eligible Own Funds
• EPS: Earnings Per Share
• ESG: Environmental, Social, and Governance
• ESMA: European Securities and Markets Authority
• EU: European Union
• EUR: Euro
• FX: Foreign Exchange
• GAAP: Generally Accepted Accounting Principles
• GEP: Gross Earned Premium
• GWP: Gross Written Premiums
• HKD: Hong Kong Dollar
• HY: High Yield
• IFE: Insurance Finance Expenses
• IFRS: International Financial Reporting Standards
• IG: Investment Grade
• JPY: Japanese Yen
• LATAM: Latin America
• LTV: Loan-to-Value
• MSCI: Morgan Stanley Capital International
• MX: Mexico
• NA: North America
• NB CSM: New Business Contractual Service Margin
• NBV: New Business Value
• NHG: Nationale Hypotheek Garantie
• NPS: Net Promoter Score
• OCI: Other Comprehensive Income
• PAA: Premium Allocation Approach
• PE: Private Equity
• PVEP: Present Value of Expected Profits
• PYD: Prior Years' Reserve Development
• RCG: Reinsurance Cost of Guarantees
• ROE: Return On Equity
• SCR: Solvency Capital Requirement
• SHE: Shareholders' Equity
• SME: Small and Medium-sized Enterprises
• TVOG: Time Value of Options and Guarantees
• UEPS: Underlying Earnings Per Share
• UK: United Kingdom
• US: United States
• USD: United States Dollar
• VAT: Value Added Tax
• VFA: Variable Fee Approach